Positron emission tomography in primary brain tumours using cobalt-55

Nuclear Medicine Communications

Volumn 18, Issue 8, 1997, Pages 734-740

  Jansen, H M ^a,b   Dierckx, R A ^b   Korf, J ^a   Paans, A M ^a   Minderhoud, J M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT; COBALT 55; COBALT CHLORIDE; GADOLINIUM PENTETATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BIOPSY; BRAIN TUMOR; CALCIUM TRANSPORT; CASE REPORT; CELL DEATH; COMPUTER ASSISTED TOMOGRAPHY; DRUG UPTAKE; GLIOBLASTOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ACTIVATION; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0030773181     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199708000-00007     Document Type: Article

References (28)

1. Burkard R, Kaiser KP, Wielcr H et al. Contribution of thallium-201-SPECT to the grading of tumorous alterations of the brain. Neurosurg Rev 1992; 15: 265-273.
2. 18F]Fluor-odeoxyglucose positron emission tomography in patients with primary malignant brain tumours. Ann Neurol 1993; 33: 540-548.
3. 11C]Tyrosine positron emission tomography to localization of cerebral gliomas for biopsy. Neurosurgery 1994; 34: 994-1002.
4. Dierckx RA, Martin JJ, Dobbeleir A, Crols R, Neetens 1, De Deyn PP. Sensitivity and specificity of thallium-201 singlephoton emission tomography in the functional detection and differential diagnosis of brain tumours. Eur J Nucl Med 1994; 21: 621-633.
5. Olivero WC, Dulebohn SC, Lister JR. The use of PET in evaluating patients with primary brain tumours: Is it useful? J Neurosurf” Psych 1995; 57: 250-252.
6. Ueda T, Kaji Y, Wakisaka S et al. Time sequential single photon emission computed tomography studies in brain tumour using thallium-201. Eur J Nucl Med 1993; 20: 138-145.
7. Jinnouchi S, Hoshi H, Ohnishi T et al. Thallium-201 SPECT for predicting histological types of meningiomas. J Nucl Med 1993; 34: 2091-2094.
8. Kim KT, Black KL, Marciano D et al. Thallium-201 SPECT imaging of brain tumours: Methods and results. J Nucl Med 1990; 31: 965-969.
9. Black KL, Emerick T, Hoh C, Hawkins RA, Mazziotta J, Becker DP. Thallium-201 SPECT and positron emission tomography equal predictors of glioma grade and recurrence. Neurol Res 1994; 16: 93-166.
10. Ogawa T, Shishido F, Kanno J et al. Cerebral glioma: Evaluation with methionine PET. Radiology 1993; 186: 45-53.
11. DiChiro G. Which PET radiopharmaceutical for brain tumours? J Nucl Med 1991; 32: 1346-1348.
12. Front D, Israel O, Even-Sapir E et al. The concentration of bleomycin labeled with Co-57 in primary and metastatic tumors. Cancer 1989; 64: 988-993.
13. Jansen HML, Pruim J, Van der Vliet AM et al. Visualization of damaged brain tissue after ischemic stroke with ‘Xlo positron emission tomography. J Nucl Med 1994; 35: 456-460.
14. Jansen HML, Knollema S, c et al. Pharmacokinetics and dosimetry of 55-and 57-cobalt chloride. j Nucl Med 1996; 37: 2082-2086.
15. Jansen HML, Willemsen ATM, Sinnige LGF et al. Cobalt-55 positron emission tomography in relapsing-progressive multiple sclerosis. J Neurol Sci 1995; 132: 139-145.
16. Jansen HML, Van der Naalt J, Van Zomeren AH et al. Cobalt-55 positron emission tomography in traumatic brain injury: A pilot study. J Neurol Neurosurg Psych 1996; 60: 221-224.
17. 2 positron emission tomography. J Neurochein 1988; 50: 1798-1807.
18. Gibbons SJ, Brorson JR, Bleakman D, Chard PS, Miller RJ. Calcium influx and neurodegeneration. Ann NY Acad Sei 1993; 679: 22-33.
19. Nagy I, Pabla R, Mates C, Dray A, Woolf CJ, Urban L. Cobalt uptake enables identification of capsaicin-and bradykinin-sensitive sub-populations of rat dorsal root ganglion cells in vitro. NeuroScience 1993; 56: 241-246.
20. Williams LR, Pregenzer JF, Oostveen JA. Induction of cobalt accumulation by excitatory amino acids within neurons of the hippocampal slice. Brain Res 1992; 581: 181-189.
21. Pruss RM, Akeson RL, Racke MM, Wilburn JL. Agonist-activated cobalt uptake identifies divalent cation-permeable kainate receptors on neurons and glial cells. Neuron 1991; 7: 509-518.
22. Zülch KJ. Principles of the new World Health Organization (WHO) classification of brain tumors. NeuroRadiology 1980; 19: 59-66.
23. Bernat J, Toth G, Kovacs L. Tumour-like thallium-201 accumulation in brain infarcts: An unexpected finding on single-photon emission tomography. Eur J Nucl Med 1994; 21: 191-195.
24. Krishna L, Slizofski WJ, Katsetos CD et al. Abnormal intracerebral thallium localization in a bacterial brain abscess. J Nucl Med 1992; 33: 2017-2019.
25. Castronovo FP. Tl-labelled TIC1 dosimetery revisited. Nucl Med Common 1993; 14: 104-107.
26. Ricci M, Pantano P, Pierallini A et al. Relationship between thallium-201 uptake by supratentorial glioblastomas and their morphological characteristics on magnetic resonance imaging. Eur J Nucl Med 1996; 5: 524-529.
27. Jansen HML, DeCoo D, Willemsen ATM et al. Co-registration of PET and MRI in different courses of MS using cobalt-55 as a calcium tracer. J Cereb Blood Flow Metab (in press).
28. Jansen HML, DeCoo D, Willemsen ATM et al. Co-registration of PET and MRI in different courses of MS using cobalt-55 as a calcium tracer. J Nucl Med (in press).